On 23 and 24 April 2026, Fondazione HEAL Italia will promote and organise in China the CDDisease 10th Meeting “Precision Medicine Symposium”, a bilateral event of global significance co-organised in collaboration with Soochow University and CDDpress/Springer Nature, to be held in the prestigious setting of the Nanbanyuan Academy (South Half Garden) in Suzhou.
Following recent agreements in North America, this initiative continues Fondazione HEAL Italia’s internationalisation journey, strengthening its scientific bridge with the East.
The symposium represents a crucial opportunity for dialogue between Italian and Chinese scientific excellence, with the aim of integrating knowledge in genomics, artificial intelligence, and personalised therapies to accelerate the transition towards a medicine “for each individual”.
As underlined by HEAL Italia’s mission, Precision Medicine is not merely a technological challenge, but a cultural choice that places the person at its centre, integrating omic, clinical, and environmental data to build tailored care pathways.
Programme
The agenda (click here for details) features high-profile thematic sessions bringing together leading experts in the field, including HEAL Italia’s Scientific Director, Prof. Mauro Piacentini, and the coordinator of the International Board, Prof. Gerry Melino, alongside numerous Chinese and Italian speakers.
Key topics across the sessions include:
- Cancer & Disease: analysis of molecular mechanisms and new therapeutic frontiers.
- Cell Death & Immunity: in-depth exploration of immune response and programmed cell death in the context of complex pathologies.
- Innovation and AI: the role of artificial intelligence in advanced diagnostics and patient stratification.
- Biobanks and Infrastructures: data and biological sample management models for translational research.
Towards Permanent International Cooperation
The Suzhou event is not merely a knowledge-sharing occasion, but the foundation for future clinical and research collaborations. Fondazione HEAL Italia’s presence in China underscores the Foundation’s commitment to acting as a catalyst for Italian innovation, connecting our national ecosystem to the world’s leading Life Sciences hubs.
Beyond China, the Foundation continues to monitor strategic markets including the United Arab Emirates, the United Kingdom, Germany, France, and Japan — key markets in terms of investment volumes and technological capacity in precision medicine.
Click below to view the full symposium agenda and discover the speakers involved, or write to: info@healitalia.eu